Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
“Physical X-ray attenuation via iodine content” describes the principle that iodine, owing to its high atomic number (53) and K-shell binding energy (33.2 keV), strongly absorbs X-rays at energies typical for diagnostic imaging[1][4][5]. This property is harnessed in clinical practice by formulating iodinated contrast agents, which, when introduced into the body, markedly increase the absorption of X-rays in tissues where they accumulate, improving image contrast and enabling visualization of vascular structures, organs, or pathological changes[1][5][8]. Iodine’s attenuation characteristics are strictly physical (photoelectric effect, K-edge absorption) and not due to a biological or molecular-specific target. Use of this phenomenon is central to CT, angiography, and a variety of radiological techniques. However, the reliance on iodine for contrast introduces secondary concerns, such as potential nephrotoxicity or rare, delayed DNA/radiation damage mediated by the increased local radiation dose[3][5].
Increases absorption of X-rays through the photoelectric effect, due to the high atomic number of iodine (Z = 53) K-edge absorption at 33.2 keV, leading to strong attenuation at diagnostic imaging energies
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Physical X-ray attenuation via iodine content.